U.S. Trade Distributors Stock News

In recent days, Symbotic announced a collaboration with Nyobolt to enhance the performance and durability of its SymBot autonomous mobile robots, while ongoing demand for the company’s warehouse automation tools continues to be reinforced by artificial intelligence adoption and a strong US$22.4 billion backlog. Symbotic’s commercial agreements, particularly its partnership with Walmart, and advances in automation technology have positioned it to further streamline logistics operations across...

MGE Energy (MGEE) has caught some fresh attention following a recent shift in its stock price over the past month. There has been quiet resilience in this utility player, which makes it an interesting stock to revisit for long-term investors. See our latest analysis for MGE Energy. While MGE Energy’s share price has slipped around 9% year-to-date, this comes after a strong multi-year run, with the total shareholder return up nearly 39% over three years. The recent move hints at a pause in...

Recursion Pharmaceuticals (RXRX) caught Wall Street’s attention again this week as a wave of new AI-driven partnerships and technology upgrades put its platform in the spotlight. The company’s leadership presence at high-profile conferences is also adding to the buzz. See our latest analysis for Recursion Pharmaceuticals. Following several AI-driven collaborations and high-profile conference appearances, Recursion’s 30-day share price return has surged by 19.35%, even as its year-to-date...

Artiva Biotherapeutics (ARTV) recently secured Fast Track Designation from the U.S. FDA for its AlloNK therapy in combination with rituximab, a treatment aimed at refractory rheumatoid arthritis. This recognition has captured significant market attention. See our latest analysis for Artiva Biotherapeutics. Artiva Biotherapeutics shares rocketed after news of the FDA Fast Track Designation, notching a remarkable 108.7% 1-month share price return and delivering 132.9% over the past 90 days...

Trying to figure out what to do with Kohl's stock right now? You are not alone. Plenty of investors are tuning in after a rollercoaster few months, with headlines ranging from analysts bumping up their price targets to the stock becoming a center of “meme” stock buzz. Despite short-term swings, uncertainty, and even some skepticism about how the company is handling its bills, Kohl's shares have attracted lots of attention from retail investors hoping for a turnaround. Let us unpack the...

Array Technologies (ARRY) has caught the market’s attention after a series of analyst upgrades and its recent acquisition of APA Solar. Industry watchers are now keen to see how these moves will impact the company’s next phase. See our latest analysis for Array Technologies. After a strong run on the back of analyst upgrades and the APA Solar deal, Array Technologies’ 1-month share price return stands at 8.4%, with a remarkable 24% gain over the last 90 days. Momentum is clearly building, and...

Bank of America (BAC) just posted third-quarter results that outpaced expectations, driven by impressive consumer and investment banking strength. Net interest income climbed year over year, and management raised its guidance for the fourth quarter. See our latest analysis for Bank of America. Bank of America’s recent momentum is hard to ignore. After delivering a standout quarter and announcing new preferred dividends, the share price has climbed to $51.28, with a year-to-date share price...

Costamare (NYSE:CMRE) has issued 1,200 Series F high-vote, non-economic preferred shares to the Konstantakopoulos family, increasing their voting power to 75.7%. This move helps the company align with new Chinese rules that restrict U.S. control in vessel operations. See our latest analysis for Costamare. Costamare’s latest move to shore up family control comes after a strong run for shareholders. The stock’s three-year total return is an impressive 84%, with a five-year total return topping...

In the past week, SIMO announced that TD SYNNEX would become its global distribution partner within the SIMO Alliance Program, expanding access to SIMO’s AI-powered multi-carrier connectivity solutions and vSIM technology for partners and customers worldwide. This collaboration enables TD SYNNEX to further broaden its product offerings in advanced connectivity and leverages its global logistics capabilities to deliver seamless cellular network solutions through its extensive distribution...

AeroVironment (AVAV) stock has attracted attention in recent weeks, largely driven by its recent price momentum and solid financial performance. Shares are up 26% over the past month, prompting investors to take a fresh look at the company's trajectory. See our latest analysis for AeroVironment. After surging more than 25% in the past month, AeroVironment's share price momentum is drawing interest as expectations remain high and yearly gains are strong. While a sharp 14% drop this past week...

Kadant Inc. ( NYSE:KAI ), is not the largest company out there, but it saw a decent share price growth of 11% on the...

Gates Industrial's (NYSE:GTES) stock up by 5.9% over the past three months. As most would know, long-term fundamentals...

Solaris Energy Infrastructure announced on October 16, 2025 that Amanda Brock has been appointed as Co-Chief Executive Officer and to its Board of Directors, following extensive executive roles at Aris Water Solutions and within the global energy sector. Brock’s appointment brings a deep background in water, power, and infrastructure leadership, placing emphasis on water recycling and technology-driven sustainability across energy operations. We'll explore how Amanda Brock's addition to the...

Quest Diagnostics (DGX) is preparing to announce its quarterly earnings this Tuesday before the market opens. As the first in its peer group to report this season, all eyes are on the company’s results and the market reaction. See our latest analysis for Quest Diagnostics. Quest Diagnostics has been steadily regaining momentum, with a 3.2% share price return for the month and an impressive 25.5% share price return so far in 2025. Over the past year, the total shareholder return reached 31.0%,...

Earlier this month, Ocular Therapeutix announced that the US FDA granted a Special Protocol Assessment for its planned Phase 3 trials of AXPAXLI in non-proliferative diabetic retinopathy, formalizing agreement on key trial design elements necessary for regulatory submission. This regulatory milestone not only advances AXPAXLI toward late-stage development but also aligns with the company's goals to expand treatment options in high-need retinal disease indications. We'll explore how the FDA's...

Halozyme Therapeutics (HALO) has caught the attention of investors after its stock showed a modest gain today. While there is no major news event driving the move, market watchers are keeping an eye on its recent performance trends and financials. See our latest analysis for Halozyme Therapeutics. Halozyme’s latest share price moves have come after a robust stretch. The stock has delivered a 39.6% year-to-date share price return and a 29.5% total return over the past year, signaling that...

SL Green Realty (SLG) just announced its third-quarter 2025 results, showing a swing back to net income with higher revenues compared to last year. The company also unveiled major lease signings and new property acquisitions in Manhattan. See our latest analysis for SL Green Realty. Even with upbeat quarterly results and some eye-catching Manhattan acquisitions, SL Green Realty's share price hasn’t escaped the recent drag in real estate stocks. The company has logged a 1-year total...

In recent days, analysts and market participants have expressed renewed confidence in PG&E, citing easing concerns over wildfire-related liabilities and highlighting ongoing efforts in wildfire mitigation and regulatory protections under California law. This shift in perception reflects recognition of PG&E's substantial investment in wildfire risk management and the potential impact of favorable legislative frameworks on the company’s financial stability. We’ll see how this improved...

Etsy (ETSY) shares have seen some recent movement, catching the eye of investors interested in how the company is navigating a changing retail landscape. Over the past month, Etsy's stock price has risen roughly 8%. See our latest analysis for Etsy. Momentum appears to be building for Etsy, with its 1-month share price return of 8% helping push its year-to-date gain to nearly 33%. This comes despite a recent dip and stands out especially given the platform’s longer-term three- and five-year...

SEALSQ Corp unveiled an integrated strategy following its acquisition of IC’Alps, outlining a multi-phase roadmap for post-quantum secure hardware, partnerships across defense, finance, energy, and a significant capital raise to accelerate commercialization in the U.S. market. This marks a pivotal move as SEALSQ positions itself as the only provider capable of delivering secure hardware solutions for quantum-resistant applications across catalog, custom, and IP-based integrated circuits, all...

If you have been watching Take-Two Interactive Software’s stock lately, you have probably noticed some eye-catching movement. Whether you are an investor deciding whether to buy, sell, or just hold on, it can feel like every headline brings a new twist. Over the past twelve months, Take-Two’s stock has jumped an impressive 66.6%, vastly outperforming broader market averages. Even when looking at a longer time frame, the growth is hard to ignore, with the stock up 112.3% over the last three...

Origin Bancorp (OBK) saw its share price move after fresh concerns emerged across regional banks, as loan quality issues were disclosed by Zions Bancorp and Western Alliance Bancorp. Investors are keeping a close eye on sector-wide credit risks. See our latest analysis for Origin Bancorp. It has been a choppy ride for Origin Bancorp, with investor sentiment swaying on shifting sector risks. This past month alone, the share price fell 8.1% before landing at $32.84, and yet its total return...

Tempus AI (TEM) has just unveiled a multi-year partnership with Whitehawk Therapeutics, using its proprietary real-world dataset to drive biomarker-focused research. The new collaboration focuses on advancing targeted therapies for lung and gynecological cancers. See our latest analysis for Tempus AI. Tempus AI’s latest moves are turning industry heads, with a string of recent partnership wins and industry presentations highlighting its momentum in precision oncology. Riding a wave of...

Brookfield Business (NYSE:BBUC) shares set a fresh record on news the company will streamline its corporate structure by shifting from a dual-entity framework to a single, publicly traded Canadian corporation named BBU Inc. See our latest analysis for Brookfield Business. This breakout to record highs seems to reflect optimism around the company's restructuring plans. Investors have warmed to the idea that a streamlined structure could unlock value, which has helped fuel the impressive 46.5%...